chr3-51941806-G-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_004704.5(RRP9):c.62C>A(p.Ala21Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000781 in 1,574,142 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_004704.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RRP9 | NM_004704.5 | c.62C>A | p.Ala21Glu | missense_variant | 1/15 | ENST00000232888.7 | NP_004695.1 | |
RRP9 | XM_047449172.1 | c.-87C>A | 5_prime_UTR_variant | 1/15 | XP_047305128.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RRP9 | ENST00000232888.7 | c.62C>A | p.Ala21Glu | missense_variant | 1/15 | 1 | NM_004704.5 | ENSP00000232888.6 |
Frequencies
GnomAD3 genomes AF: 0.0000788 AC: 12AN: 152228Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000117 AC: 22AN: 187970Hom.: 0 AF XY: 0.000143 AC XY: 15AN XY: 104842
GnomAD4 exome AF: 0.0000781 AC: 111AN: 1421914Hom.: 0 Cov.: 31 AF XY: 0.0000907 AC XY: 64AN XY: 705654
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152228Hom.: 0 Cov.: 33 AF XY: 0.0000941 AC XY: 7AN XY: 74376
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 04, 2024 | The c.62C>A (p.A21E) alteration is located in exon 1 (coding exon 1) of the RRP9 gene. This alteration results from a C to A substitution at nucleotide position 62, causing the alanine (A) at amino acid position 21 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at